Stock Events

Stock Events

KalVista Pharmaceuticals (KALV) Q3 2025 Earnings

11SepConfirmed

Q4 2024

Q1 2025

Q3 2025

Q3 2025

-1.12

-1.01

-0.91

-0.8

Details

Expected EPS

-0.953333

Actual EPS

-1.12

Surprise EPS

-0.17

Surprise Percent

+17.48%

Description

KalVista Pharmaceuticals (KALV) has reported earnings of -1.12 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.